Immunotherapy, Molecular Testing Propel Dramatic Changes in Lung Cancer Care – OncLive
OncLive |
Immunotherapy, Molecular Testing Propel Dramatic Changes in Lung Cancer Care
OncLive In a recent interview with OncLive, Joel Neal, MD, PhD, assistant professor of Medicine (Oncology), Stanford University Medical Center, discussed how recent immunotherapy advances are transitioning the field of NSCLC and how the impact of molecular … |
